rdfs:comment
| - Esteban González Burchard, M.D., M.P.H. is an American physician-scientist, specializing in pulmonary and critical care medicine, asthma, clinical pharmacology, genetics, pharmacogenetics, genetic ancestry, gene-environment interactions, epidemiology, and health disparities. He is the Founder and Director of the Asthma Collaboratory and the Center for Genes, Environment, and Health at the University of California, San Francisco (UCSF). He is a distinguished tenured professor in the Schools of Pharmacy and Medicine at UCSF and holds dual appointments in the Department of Medicine and the Department of Bioengineering and Therapeutic Sciences. (en)
|
has abstract
| - Esteban González Burchard, M.D., M.P.H. is an American physician-scientist, specializing in pulmonary and critical care medicine, asthma, clinical pharmacology, genetics, pharmacogenetics, genetic ancestry, gene-environment interactions, epidemiology, and health disparities. He is the Founder and Director of the Asthma Collaboratory and the Center for Genes, Environment, and Health at the University of California, San Francisco (UCSF). He is a distinguished tenured professor in the Schools of Pharmacy and Medicine at UCSF and holds dual appointments in the Department of Medicine and the Department of Bioengineering and Therapeutic Sciences. Dr. González Burchard is best known for his work in the health disparities of asthma. Specifically, he founded and directs the largest study of minority children with asthma in the United States, called the Asthma Translational Genomics Collaborative (ATGC). This study involves whole genome sequencing of more than 15,580 minority children with and without asthma. All children with asthma have spirometry and bronchodilator drug response measures. Burchard is also affiliated with the UCSF Institute for Human Genetics and the UCSF Lung Biology Center. Dr. González Burchard's team has a wide breadth of expertise in medicine, clinical pharmacology, genetics, epidemiology, and statistics. The lab is multi-disciplinary and cross-functional at its core; statisticians, epidemiologists, physicians, and biologists work together to foster cross-fertilization of ideas in approaching asthma research. Dr. González Burchard's team focuses on improving health through therapeutics, medicines, medical devices, and diagnostic tests, and is leading the field in asthma genetics. Recently his team was awarded nearly $10 million from the National Heart Lung and Blood Institute to study the early life determinants of asthma in Puerto Rican children. His team in collaboration with National Jewish Health and Centro de Neumología Pediátrica created the Puerto Rican Infant Metagenomic and Epidemiologic study of Respiratory Outcomes (PRIMERO), a birth cohort study of pregnant mothers and their newborns with the aim to help patients and healthcare providers better understand how and why asthma disproportionately impacts Puerto Ricans. (en)
|